333 related articles for article (PubMed ID: 27465588)
21. Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients.
Annunzio K; Bhatta S; Hanel W; Zhao Q; Owen M; Rosen H; Voorhees TJ; Bond DA; Sawalha Y; Sigmund AM; Alinari L; Baiocchi RA; Maddocks KJ; Jones D; Christian B; Epperla N
Hematol Oncol; 2024 May; 42(3):e3278. PubMed ID: 38726682
[TBL] [Abstract][Full Text] [Related]
22. Impact of the introduction of rituximab in first-line follicular lymphoma: a retrospective study of 247 unselected patients referred to a single institution with a long-term follow-up.
Nicolas-Virelizier E; Ségura-Ferlay C; Ghesquières H; Chassagne-Clément C; Gargi T; Biron P; Belhabri A; Rey P; Faurie P; Chabaud S; Sebban C
Hematol Oncol; 2015 Mar; 33(1):1-8. PubMed ID: 24496668
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.
Maurer MJ; Ghesquières H; Link BK; Jais JP; Habermann TM; Thompson CA; Haioun C; Allmer C; Johnston PB; Delarue R; Micallef IN; Peyrade F; Inwards DJ; Ketterer N; Farooq U; Fitoussi O; Macon WR; Molina TJ; Syrbu S; Feldman AL; Slager SL; Weiner GJ; Ansell SM; Cerhan JR; Salles GA; Witzig TE; Tilly H; Nowakowski GS
J Clin Oncol; 2018 Jun; 36(16):1603-1610. PubMed ID: 29672223
[TBL] [Abstract][Full Text] [Related]
24. Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study.
Bachy E; Estell JA; Van de Neste E; Bouabdallah R; Bargay J; Delmer A; Gelas-Dore B; Gomes da Silva M; Fitoussi O; Belada D; Maisonneuve H; Intragumtornchai T; Lamy T; Dartigues P; Seymour JF; Salles G
Am J Hematol; 2016 Jun; 91(4):410-5. PubMed ID: 26799234
[TBL] [Abstract][Full Text] [Related]
25. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment.
Arcaini L; Colombo N; Passamonti F; Burcheri S; Orlandi E; Brusamolino E; Della Porta M; Rumi E; Montanari F; Pascutto C; Paulli M; Lazzarino M
Leuk Res; 2006 Mar; 30(3):277-82. PubMed ID: 16112730
[TBL] [Abstract][Full Text] [Related]
26. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A
Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035
[TBL] [Abstract][Full Text] [Related]
27. Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States.
Nabhan C; Zhou X; Day BM; Dawson K; Zelenetz AD; Friedberg JW; Cerhan JR; Link BK; Flowers CR
Am J Hematol; 2016 Aug; 91(8):770-5. PubMed ID: 27124800
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of Treatment in Slovene Follicular Lymphoma Patients.
Južnič Šetina T; Borštnar S; Jezeršek Novaković B
Clin Lymphoma Myeloma Leuk; 2015 Oct; 15(10):586-91. PubMed ID: 26423702
[TBL] [Abstract][Full Text] [Related]
29. Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.
Ghesquieres H; Slager SL; Jardin F; Veron AS; Asmann YW; Maurer MJ; Fest T; Habermann TM; Bene MC; Novak AJ; Mareschal S; Haioun C; Lamy T; Ansell SM; Tilly H; Witzig TE; Weiner GJ; Feldman AL; Dogan A; Cunningham JM; Olswold CL; Molina TJ; Link BK; Milpied N; Cox DG; Salles GA; Cerhan JR
J Clin Oncol; 2015 Nov; 33(33):3930-7. PubMed ID: 26460308
[TBL] [Abstract][Full Text] [Related]
30. Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups.
Batlevi CL; Sha F; Alperovich A; Ni A; Smith K; Ying Z; Soumerai JD; Caron PC; Falchi L; Hamilton A; Hamlin PA; Horwitz SM; Joffe E; Kumar A; Matasar MJ; Moskowitz AJ; Moskowitz CH; Noy A; Owens C; Palomba LM; Straus D; von Keudell G; Zelenetz AD; Seshan VE; Younes A
Blood Cancer J; 2020 Jul; 10(7):74. PubMed ID: 32678074
[TBL] [Abstract][Full Text] [Related]
31. A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait.
El-Galaly TC; Bilgrau AE; de Nully Brown P; Mylam KJ; Ahmad SA; Pedersen LM; Gang AO; Bentzen HH; Juul MB; Bergmann OJ; Pedersen RS; Nielsen BJ; Johnsen HE; Dybkaer K; Bøgsted M; Hutchings M
Br J Haematol; 2015 May; 169(3):435-44. PubMed ID: 25709094
[TBL] [Abstract][Full Text] [Related]
32. Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in assessing prognosis and predicting first-line treatment efficacy in follicular lymphoma patients.
Formica V; Norman AR; Cunningham D; Wotherspoon A; Oates J; Chong G
Acta Haematol; 2009; 122(4):193-9. PubMed ID: 19887775
[TBL] [Abstract][Full Text] [Related]
33. Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma.
Wudhikarn K; Bunworasate U; Julamanee J; Lekhakula A; Ekwattanakit S; Khuhapinant A; Niparuck P; Chuncharunee S; Numbenjapon T; Prayongratana K; Kanitsap N; Wongkhantee S; Makruasri N; Wong P; Norasetthada L; Nawarawong W; Sirijerachai C; Chansung K; Suwanban T; Praditsuktavorn P; Intragumtornchai T;
Hematol Oncol; 2019 Dec; 37(5):578-585. PubMed ID: 31702065
[TBL] [Abstract][Full Text] [Related]
34. Trends in excess mortality in follicular lymphoma at a population level.
Mounier M; Bossard N; Belot A; Remontet L; Iwaz J; Dandoit M; Girard-Boulanger S; Herry A; Woronoff AS; Casasnovas RO; Maynadié M; Giorgi R;
Eur J Haematol; 2015 Feb; 94(2):120-9. PubMed ID: 24952984
[TBL] [Abstract][Full Text] [Related]
35. Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study Group.
Wudhikarn K; Bunworasate U; Julamanee J; Lekhakula A; Ekwattanakit S; Khuhapinant A; Niparuck P; Chuncharunee S; Numbenjapon T; Prayongratana K; Kanitsap N; Wongkhantee S; Makruasi N; Wong P; Norasetthada L; Nawarawong W; Sirijerachai C; Chansung K; Suwanban T; Praditsuktavorn P; Intragumtornchai T
Leuk Lymphoma; 2020 Nov; 61(11):2614-2621. PubMed ID: 32573294
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of clinical features and prognostic factors in 59 cases of follicular lymphoma].
Zhang W; Wang J; Wan W; Wan WL; Wang JJ; Hu K; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1448-53. PubMed ID: 24370027
[TBL] [Abstract][Full Text] [Related]
37. Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.
Ruella M; Filippi AR; Bruna R; Di Russo A; Magni M; Caracciolo D; Passera R; Matteucci P; Di Nicola M; Corradini P; Parvis G; Gini G; Olivieri A; Ladetto M; Ricardi U; Tarella C; Devizzi L
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):783-91. PubMed ID: 26972651
[TBL] [Abstract][Full Text] [Related]
38. Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome.
Sorigue M; Mercadal S; Alonso S; Fernández-Álvarez R; García O; Moreno M; Pomares H; Alcoceba M; González-García E; Motlló C; González-Barca E; Martin A; Sureda A; Caballero D; Ribera JM; Sancho JM
Hematol Oncol; 2017 Dec; 35(4):520-527. PubMed ID: 28156010
[TBL] [Abstract][Full Text] [Related]
39. Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy.
Mir F; Mattiello F; Grigg A; Herold M; Hiddemann W; Marcus R; Seymour JF; Bolen CR; Knapp A; Nielsen T; Casulo C
Am J Hematol; 2020 Dec; 95(12):1503-1510. PubMed ID: 32815559
[TBL] [Abstract][Full Text] [Related]
40. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
Găman AM
Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
